Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
128K
-
Shares change
-
+550
-
Total reported value, excl. options
-
$2.53M
-
Value change
-
+$10.9K
-
Number of buys
-
1
-
Price
-
$19.78
Significant Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA) as of Q4 2024
2 filings reported holding KNSA - Kiniksa Pharmaceuticals Intern - COM as of Q4 2024.
Kiniksa Pharmaceuticals Intern - COM (KNSA) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 128K shares
.
Largest 2 shareholders include HARBOR CAPITAL ADVISORS, INC. (98.1K shares) and Birchview Capital, LP (30K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.